Patients with pancreatic diseases (chronic pancreatitis) had a higher risk of developing PDAC and thus the expression of CTSE in pancreatic diseases might be the key to early PDAC detection and PDAC progression. This evidence concerns the gene CTSE and pancreas disorder.